121 related articles for article (PubMed ID: 9310720)
1. Inhibition of elicitation of contact dermatitis in humans by mometasone furoate: evaluation by means of 20-MHz B scanning associated with image analysis.
Di Nardo A; Giusti G; Mantovani L; Bianchi B; Seidenari S
Dermatology; 1997; 195(2):137-41. PubMed ID: 9310720
[TBL] [Abstract][Full Text] [Related]
2. The therapeutic efficacy of mometasone furoate cream 0.1% applied once daily vs clobetasol propionate cream 0.05% applied twice daily in chronic eczema.
Goh CL; Lim JT; Leow YH; Ang CB; Kohar YM
Singapore Med J; 1999 May; 40(5):341-4. PubMed ID: 10489492
[TBL] [Abstract][Full Text] [Related]
3. Comparison of skin atrophy and vasoconstriction due to mometasone furoate, methylprednisolone and hydrocortisone.
Hoffmann K; Auer T; Stücker M; Hoffmann A; Altmeyer P
J Eur Acad Dermatol Venereol; 1998 Mar; 10(2):137-42. PubMed ID: 9553910
[TBL] [Abstract][Full Text] [Related]
4. Parallel intraindividual evaluation of the vasoconstrictory action and the anti-allergic activity of topical corticosteroids.
Seidenari S; Di Nardo A; Mantovani L; Giannetti A
Exp Dermatol; 1997 Apr; 6(2):75-80. PubMed ID: 9209888
[TBL] [Abstract][Full Text] [Related]
5. Eumovate (clobetasone butyrate) 0.05% cream with its moisturizing emollient base has better healing properties than hydrocortisone 1% cream: a study in nickel-induced contact dermatitis.
Parneix-Spake A; Goustas P; Green R
J Dermatolog Treat; 2001 Dec; 12(4):191-7. PubMed ID: 12241627
[TBL] [Abstract][Full Text] [Related]
6. Comparison of mometasone furoate 0.1% cream and hydrocortisone 1.0% cream in the treatment of childhood atopic dermatitis.
Vernon HJ; Lane AT; Weston W
J Am Acad Dermatol; 1991 Apr; 24(4):603-7. PubMed ID: 2033138
[TBL] [Abstract][Full Text] [Related]
7. Sensitization studies with mometasone furoate, tixocortol pivalate, and budesonide in the guinea pig.
Bruze M; Bjorkner B; Dooms-Goossens A
Contact Dermatitis; 1996 Mar; 34(3):161-4. PubMed ID: 8833457
[TBL] [Abstract][Full Text] [Related]
8. Cross-reactions to desoximetasone and mometasone furoate in a patient with multiple topical corticosteroid allergies.
Donovan JC; Dekoven JG
Dermatitis; 2006 Sep; 17(3):147-51. PubMed ID: 16956468
[TBL] [Abstract][Full Text] [Related]
9. A comparison of once-daily application of mometasone furoate 0.1% cream compared with twice-daily hydrocortisone valerate 0.2% cream in pediatric atopic dermatitis patients who failed to respond to hydrocortisone: mometasone furoate study group.
Lebwohl M
Int J Dermatol; 1999 Aug; 38(8):604-6. PubMed ID: 10487451
[No Abstract] [Full Text] [Related]
10. Eumovate (clobetasone butyrate 0.05%) cream: a review of clinical efficacy and safety.
Goustas P; Cork MJ; Higson D
J Dermatolog Treat; 2003 Jun; 14(2):71-85. PubMed ID: 12775314
[TBL] [Abstract][Full Text] [Related]
11. Once-daily 0.1% mometasone furoate cream versus twice-daily 0.1% betamethasone valerate cream in the treatment of a variety of dermatoses.
Viglioglia P; Jones ML; Peets EA
J Int Med Res; 1990; 18(6):460-7. PubMed ID: 2292327
[TBL] [Abstract][Full Text] [Related]
12. Long-term, intermittent treatment of chronic hand eczema with mometasone furoate.
Veien NK; Olholm Larsen P; Thestrup-Pedersen K; Schou G
Br J Dermatol; 1999 May; 140(5):882-6. PubMed ID: 10354026
[TBL] [Abstract][Full Text] [Related]
13. Cross-sensitization to mometasone furoate in patients with corticosteroid contact allergy.
Räsänen L; Tuomi ML
Contact Dermatitis; 1992 Nov; 27(5):323-5. PubMed ID: 1493689
[No Abstract] [Full Text] [Related]
14. [Comparison of activity of different topical corticosteroid creams and ointments using a vasoconstriction assay: superiority of hydrocortisone butyrate over hydrocortisone].
Korting HC; Maslen K; Gross G; Willers C
J Dtsch Dermatol Ges; 2005 May; 3(5):348-53. PubMed ID: 16372801
[TBL] [Abstract][Full Text] [Related]
15. Comparison of effects of tacrolimus ointment and mometasone furoate cream on the epidermal barrier of patients with atopic dermatitis.
Dähnhardt-Pfeiffer S; Dähnhardt D; Buchner M; Walter K; Proksch E; Fölster-Holst R
J Dtsch Dermatol Ges; 2013 May; 11(5):437-43. PubMed ID: 23551950
[TBL] [Abstract][Full Text] [Related]
16. In vivo assessment of the atrophogenic potency of mometasone furoate, a newly developed chlorinated potent topical glucocorticoid as compared to other topical glucocorticoids old and new.
Kerscher MJ; Hart H; Korting HC; Stalleicken D
Int J Clin Pharmacol Ther; 1995 Apr; 33(4):187-9. PubMed ID: 7620686
[TBL] [Abstract][Full Text] [Related]
17. An open study of efficacy and safety of long-term treatment with mometasone furoate fatty cream in the treatment of adult patients with atopic dermatitis.
Faergemann J; Christensen O; Sjövall P; Johnsson A; Hersle K; Nordin P; Edmar B; Svensson A
J Eur Acad Dermatol Venereol; 2000 Sep; 14(5):393-6. PubMed ID: 11305382
[TBL] [Abstract][Full Text] [Related]
18. Mometasone furoate versus betamethasone vale-rate in the treatment of allergic contact dermatitis.
Grandolfo M; Vena GA; Angelini G; Bianchi B
J Eur Acad Dermatol Venereol; 1999 Mar; 12(2):178-80. PubMed ID: 10343953
[No Abstract] [Full Text] [Related]
19. Topical mometasone furoate for vulvar lichen sclerosus.
Cattaneo A; De Magnis A; Botti E; Sonni L; Carli P; Taddei GL
J Reprod Med; 2003 Jun; 48(6):444-8. PubMed ID: 12856516
[TBL] [Abstract][Full Text] [Related]
20. Assessment of topical corticosteroid activity on experimentally induced contact dermatitis: echographic evaluation with binary transformation and image analysis.
Seidenari S; Di Nardo A; Giannetti A
Skin Pharmacol; 1993; 6(2):85-91. PubMed ID: 8352953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
